Physician profile
Anne Holland Johnson
NPI 1801949649
$814,748.39
in general payments reported to CMS, 2019-2025
13 companies · $266K in 2025
The $266K reported for 2025 was more than what 98% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2020: $34K · 2021: $63K · 2022: $71K · 2023: $164K · 2024: $171K · 2025: $266K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $321K · Royalty Or License: $228K · Travel and Lodging: $47K · Food and Beverage: $4,707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $320,665.88 |
| Royalty Or License | $227,715.61 |
| Travel and Lodging | $47,108.51 |
| Food and Beverage | $4,707.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novastep INC. | $430,162.36 | 2019-2025 | Nexis, Peca Bunion Correction System, Peca-C Compressive Implants |
| Treace Medical Concepts, INC. | $352,230.06 | 2023-2025 | |
| Medartis INC. | $12,668.00 | 2019 | |
| Arthrex, INC. | $6,941.67 | 2021-2022 | |
| Wright Medical Technology, INC. | $5,937.50 | 2019 | |
| Zimmer Biomet Holdings, INC. | $3,375.00 | 2020-2021 | |
| Depuy Synthes Products, INC. | $1,170.00 | 2022 | |
| Synthes USA Products LLC | $1,170.00 | 2022 | |
| Royal Biologics, INC. | $747.81 | 2020-2021 | |
| Medshape, INC. | $157.87 | 2023 | |
| Lifenet Health | $98.58 | 2025 | Duallink |
| Abbvie INC. | $55.74 | 2024 | |
| Genzyme Corporation | $33.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.